Clinical Scorecard: Utilizing Arterial Spin Labeling MRI for Monitoring Brain Tumors: Is the Creation of Cerebral Blood Flow Maps Necessary?
At a Glance
Category
Detail
Condition
Brain tumors with challenges in differentiating tumor progression from treatment-related abnormalities
Key Mechanisms
Arterial Spin Labeling (ASL) MRI measures perfusion using magnetically labelled endogenous blood water without contrast agents; perfusion differences help distinguish tumor progression (increased perfusion) from treatment effects (decreased perfusion)
Target Population
Patients undergoing surveillance for intra-axial brain tumors
Care Setting
Clinical radiology departments using 3T MRI scanners for brain tumor monitoring
Key Highlights
Conventional MRI cannot reliably differentiate tumor progression from treatment-related changes due to similar contrast enhancement patterns.
ASL MRI is a non-invasive perfusion technique using endogenous blood labeling, avoiding contrast agents and susceptibility artifacts common in DSC MRI.
Semiquantitative and visual assessments of ASL perfusion-weighted images (ASL-PWI) may correlate highly with quantitative cerebral blood flow (CBF) maps, potentially simplifying clinical workflow.
Guideline-Based Recommendations
Diagnosis
Use ASL MRI to assess perfusion differences between tumor tissue and normal appearing white matter to aid differentiation of tumor progression versus treatment effects.
Apply region of interest (ROI) analysis comparing lesion perfusion to normal tissue for semiquantitative assessment.
Visual assessment of relative hyperperfusion areas on ASL-PWI maps can be used as an efficient alternative to quantitative CBF mapping.
Management
Incorporate ASL MRI into routine brain tumor surveillance protocols to improve diagnostic accuracy without the need for contrast agents.
Consider omitting quantitative CBF map generation if semiquantitative or visual assessments provide sufficient clinical information, to streamline workflow.
Monitoring & Follow-up
Perform follow-up ASL MRI scans to monitor changes in perfusion indicative of tumor progression or treatment-related abnormalities.
Use consistent ROI placement and imaging parameters to ensure comparability across serial scans.
Risks
Be aware of ASL MRI’s lower signal-to-noise ratio and longer scan times compared to DSC MRI.
Recognize potential unfamiliarity and complexity in ASL post-processing and interpretation among clinicians.
Patient & Prescribing Data
Patients with treated intra-axial brain tumors undergoing MRI surveillance
ASL MRI provides a non-invasive method to monitor tumor perfusion changes without contrast agents, facilitating differentiation between tumor progression and treatment effects, potentially reducing need for additional imaging or invasive procedures.
Clinical Best Practices
Use 3D pseudocontinuous ASL sequences with background suppression on 3T MRI scanners for optimal perfusion imaging.
Place ROIs of approximately 70 mm2 in representative lesion areas for semiquantitative analysis.
Perform visual quality assessment of ASL images focusing on motion artifacts and tissue contrast before interpretation.
Compare lesion perfusion values to normal appearing white matter to calculate perfusion ratios.
Consider visual assessment of ASL-PWI maps as a practical alternative to quantitative CBF maps to improve workflow efficiency.
